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   Abstract- Many mental disorders are caused due to 
improper regulation of the brain and depression is one 
such. It affects both children and adults and is very 
common among teenagers. There are many challenges 
clinicians face regarding the management of this disease. 
These challenges have prompted the development of 
various neuroimaging techniques that effectively diagnose 
the condition. The main techniques are Magnetic 
resonance imaging (MRI) and Positron emission 
tomography (PET) which have gained momentum over the 
years. Advanced MRI techniques help study certain 
regions of the brain such as hippocampus and amygdala. 
Effective treatments for depression include antidepressant 
medications and brain stimulation techniques. Although 
treatments are effective for a lot of people, there is still 
room for improvement. This article (1) presents 
background on depression, its types, symptoms and risk 
factors; (2) elaborates the neuroimaging techniques used 
and reviews the various techniques adopted over the years 
to study depression; and (3) discusses the treatment 
methods that can be practised to cure depression. 
 
   Keywords- Brain Stimulation Techniques, Depression, 




ost of us feels neglected or sad due to many reasons in 
life.  It could be due to prolonged illness or sickness, 
financial issues, relationship troubles and many more.  While 
some can effectively manage their feelings, others succumb to 
the negative emotions they feel and let it overtake them. 
Therefore if someone is constantly experiencing feelings of 
sadness for a prolonged period, they may have a major 
depressive disorder (MDD) [1]. 
Depression can be defined as an illness that involves thoughts, 
feelings and mood and how they adversely affect a person’s 
health.  Globally, more than 300 million [2] people are living 
with depression.  This accounts for about 4.3% of the world’s 
population.  According to WHO’s Global Health Estimates 
2017, 4.5% of the Indian population are dealing with 
depression.  It is one of the most common disorders that affect 
the brain. It can affect anyone either indirectly or directly or 
through a friend [3]. 
There are a lot of symptoms that a depressed person can show. 
They comprise feelings of hopelessness or worthlessness [3] 
and persistent sad mood which can last up to weeks. Problems 
with sleep are also common. Some people get up at night [1] 
for something and can’t fall back to sleep again whereas 
others could be sleeping more. One of the other reasons for 
depression can be low self-esteem or social anxiety. Drug or 
alcohol abuse [1] and certain medical conditions such as 
cancer or hypothyroidism can also trigger MDD. Further 
symptoms include lack of energy and concentration and 
reduction in libido. The overall depression cycle comprises of 
the symptoms one shows during the depression and 
behavioural changes that occur along with it, as shown in Fig. 
1.  
M 
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Fig. 1. The Depression cycle
Many diagnosing techniques have been adopted over the years 
to study depression. At first, X-rays and CT scans were used 
to obtain images of the brain. But with time, neuroimaging has 
progressed and the brain scans mostly used now are MRI and 
PET, which provide much clearer images of affected 
components of the brain. They also reveal how the brain 
functions in real-time. Some relevant studies can be found in 
[4] and [5]. By comparing these scans with the normal human 
brain, researchers can gain more information about the 
similarities and differences. The differences seen are usually 
in the frontal cortex of the brain or the hippocampus [6]. On 
rare occasions, some people could have structural issues like 
the presence of a cyst or tumour that could result in 
depression. In this review, we have summarized the imaging 
techniques (1999-2015) on the utilization of MRI and PET 
scans for the detection of depression. This helps us understand 
how neuroimaging has progressed over the years. But next to 
diagnosis comes treatment which is essential in curing the 
disease. We shall look further into the various treatment 
methods in section V. 
A. Types of Depression 
   The most common types of depression are melancholia, 
psychotic depression and antenatal and postnatal depression 
which can be classified under Major Depression. The person 
shows loss of interest and pleasure in daily activities, 
experiences low moods and other symptoms. One major 
difference is that in melancholia the person begins to move 
very slowly whereas in psychotic depression the person 
experiences hallucinations, delusions or paranoia. When the 
risk of depression is increased during pregnancy in women 
[7], it contributes to prenatal or antenatal depression. If it’s 
after childbirth then it’s the postnatal depression. Persistent 
Depressive Disorder is another type of depression where the 
person is depressed continuously for a year or longer.  For 
both the conditions, ‘dysthymia’, a lower grade depressive 
disorder and ‘chronic major depression’ term is used.  
Medications and psychotherapy or both are specified for its 
treatment.  Another category is Bipolar Disorder, which is also 
called ‘manic depression’.  In this, patients have episodes with 
extreme highs and lows. The mood fluctuations range from 
low to high "depressive" periods [1], [8]. During the low 
phase, symptoms of major depression can be witnessed. 
Whether its high or low phase, both need to be treated. 
Usually lithium, a mood stabilizer is prescribed. Another type 
of depression is the Premenstrual Dysphoric Disorder 
(PMDD), where women have depression-related symptoms at 
the start of their period.  Seasonal Affective Disorder (SAD) is 
another type of depression that mostly occurs during the 
winter i.e. when there is less sunlight and length of day 
decreases. It mostly goes away by spring and summer. 
B. Risk Factors  
   The American Psychiatric Association has divided 
depression risk factors into four categories: Biochemistry, 
Genetics, Personality characteristics and Environmental 
elements. The few chemicals in brain function may predispose 
someone to depression are they are studied in Biochemistry. 
Chemicals called neurotransmitters help maintain the signal 
flow from one neuron to another brain neuron. Examples such 
as serotonin and dopamine [9] usually play a role in mood 
regulation. Genetics suggests that depression can run in 
hereditary, which adds a genetic component to acquiring the 
disease. A twin has a 70% chance of developing depression if 
the other twin has depression [9]. Research has also focussed 
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on demographic variables which include gender, social status 
and marital status [10].  Changes in personality characteristics 
are often observed in teens and adolescents although it can 
happen at any age. According to NIMH reports, the most 
chronic mood changes in adults started as high anxiety that 
occurred when they were young, noting that increased levels 
of childhood anxiety could lead to a greater risk of adult 
depression. Apart from this, the majority of mental health 
specialists think that environmental factors play a significant 
role in transforming vulnerable people into depressed masses. 
The NIMH suggests that exposure to abuse, neglect and poor 
economic conditions can make people liable to get depressed. 
Occurrences such as loss of loved one, trauma, relationship 
troubles, financial stress and stress generally can contribute to 
further enhancement of depression [9]. 
II. CHALLENGES AND CONTROVERSIES 
RELATED TO DEPRESSION 
   Depressive and anxiety disorders such as common mental 
disorders (CMD) are regularly encountered in the primary care 
unit. However, the recognition of these mental disorders is 
very poor. Less than a third clinical case only get identified. 
Diagnosis is difficult in primary care due to the high rate of 
co-morbidity amongst diverse disorders [11]. 
 
In India, effective delivery of medications to people is still a 
matter of concern. There is not much availability of medicines 
to cater to a huge population especially in rural areas.  Also, 
not much experience is there concerning the usage of 
antidepressant medicines. Not many have enough knowledge 
about how dangerous depression could be for a person’s 
health. According to a study conducted by Tessa Roberts et 
al., [12] in rural Madhya Pradesh, 86% of screen positive 
adults did not seek treatment for depression. 54% reported 
treatment cost and 56% reported a long distance to the medical 
centres as barriers. Even in the west, treatment adherence is a 
big hurdle in the overall treatment. So far, there has not been 
any convincing research from India related to improving 
treatment adherence [11]. One important discovery of a study 
was that a significant number of women [11] didn’t look for 
help or stick to particular treatment even after additional 
support from the health services. This barrier needs to be 
investigated further. 
 
III. DIAGNOSIS OF DEPRESSION 
USING NEUROIMAGING TECHNIQUES 
 
A. MRI  
   One of the most difficult problems in tackling depression 
has been the absence of scans or lack of tests in diagnosing the 
condition. Scientists however have found out a way to identify 
MDDs easily by using radio waves and magnetic waves to 
look into the internal organs of the body. Scanning is done in 
different angles in cross-sections and slices to acquire 
attenuated images. These images are sent to the computer and 
a software programme puts these cross-sections and slices 
together to obtain a picture of the organ. 
 
Three main areas where MRI reports have conveyed evident 
major differences in depressed brains are: 
 
1. Blood-brain barrier (BBB) 
   BBB is the barrier between the brain tissue and the blood 
vessels. In recent research by Dr Kenneth Wengler, 
connections between BBB and MDD using MRI method 
called as IDEALS (intrinsic diffusivity encoding of arterial 
labelled spins) i.e., 3D MRI which gives an understanding of 
brain-water permeability was studied. This study showed how 
the water movement from blood vessels into brain tissue 
through BBB took place. It was done with 14 MDD patients 
and 14 healthy members [13]-[15]. The study elucidated that 
the water movement is less in patients. This confirmed the 
disturbances in BBB, particularly in the amygdala (responsible 
for emotions) and the hippocampus. 
 
2. Connectome  
   The connectome is known as the network of complex 
connections. The deformities of the connectome using fMRI 
(shows slight changes in blood flow in the brain) were studied 
by Dr Goushi and his team from Chicago by observing 66 
adults with MDD and 66 healthy people [14], [15].  Decreased 
level of excitation and inhibition in the cortex (responsible for 
cognitive control) and amygdala were observed in the MDD 
patients. Reduced levels of excitation and inhibition were 
noted in the dorsal lateral prefrontal cortex in MDD patients 
[14], [15]. Furthermore, the elevation in the amygdala was 
observed which contributed to anxiety and negative moods. 
Further research on defects in connectome can help scientists 
identify related defects in the brain. 
 
3. Machine learning algorithm 
   A different study was done, where the brain patterns in 
depressed patients were identified. The occurrence of such 
similar patterns was searched in other patients to see if they 
were suffering from depression too. Many brain regions are 
involved in the network identified in depressed people. It can 
involve the four lobes of the brain namely, the frontal, parietal, 
temporal and occipital lobes as shown in Fig. 2 [16]. Machine 
learning and artificial learning analysis were done on the MRI 
data of 23 adults with MDD and 20 healthy patients [17]. This 
works by recognizing the patterns and learning from them to 
make new assumptions about new data sets.  
 
Fig. 2. Lobes of the cerebral cortex 
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Variations in grey and white matter density were found in 
patients with depression and are shown in Fig. 3 [17]. These 
enlarge from prefrontal to parietal lobes and include occipital 
and cerebellar regions. These same patterns were matched 
with other people who were also suffering from depression. 
The same pattern was also used in individuals with different 
ethnicity as people from different ethnicity could demonstrate 
different neural responses. It was observed that the same 
pattern of regions was found to underlie in depressed 




Fig. 3. Grey matter patterns in depression. 
B. PET  
   PET is different from other imaging procedures as it is based 
on the molecular processes that occur in the living organisms. 
The positron-emitting nuclide, usually short-lived is used in 
PET imaging. The organ of interest is scanned after injection. 
PET imaging is majorly used for studying the brain, the neuro 
molecular processes in humans and as well as in animals. 
Comparison of the brain with depression and normal brain can 
be done with PET scan [18]. As shown in Fig. 4 [19], an 
increase in green and blue areas along with a decrease in 
yellow and white colours show reduced brain functioning 
because of depression [18]. 
 
 
Fig. 4. PET image of depressed vs normal brain 
A PET study was done on 134 participants ages 18-75 by a 
team from the Research imaging centre in Toronto. The scan 
was done on 3 grey matter regions of the brain consisting of 
the insula, prefrontal cortex and anterior cingulate cortex in 
addition to 12 sub-regions [20], [21]. The study focused on 
neuro progression and microglial activation. Neuroprogression 
can be measured by translocator protein total distribution 
volume (TSPO V). The study included 3 groups: 25 patients 
with untreated depression for 10 years or more, 25 patients 
with less than 10 years of depression and 30 healthy people 
[20].  Greater TSPO V levels (29 -33% higher) were observed 
in all the three regions of the brain for individuals with longer 
and untreated depression compared to those who had shorter 
duration with no treatment [20], [21]. This implied that 
chronically advanced MDD patients and patients with a long 
period of no treatment had very high microglial activation.  
 
IV. MRI AND PET IMAGING 
METHODS ADOPTED OVER THE 
YEARS 
 
   MRI and PET scans have played a crucial role in 
understanding the pathogenesis of MDD in the last three 
decades. Many researchers performed PET study on serotonin 
receptors to identify the differences in brain patterns between 
a patient and normal person. Serotonin helps regulate mood 
and low levels of the chemical are said to be associated with 
depression. Subsequent research has focused on MRI scans 
which captured the activity of the brain in both active and 
resting state. Although these approaches help researchers 
identify and locate affected parts of the brain, none of them 
has reached the level of accuracy to define the “neural 
signature” of MDD. More recently, machine learning models 
have been applied to fMRI data to better understand brain 
connectivity and networks. 
 
I. TREATMENT METHODS 
   According to WHO, less than 50% of the depressed patients 
receive treatment. Depression can have dangerous long term 
consequences when left untreated. Therefore it is important to 
treat depression in the early stages to prevent functional and 
morphological abnormalities. Treatment measures such as 
lifestyle changes are easy for an individual with fewer 
symptoms to incorporate, however in severe cases, decision 
must be made whether the patient needs to be hospitalised or 
treated in Outpatient department (OPD). Major treatment 
methods were reviewed in this study and are discussed in 
detail below: 
 
A. Lifestyle Changes 
   Regular exercise is the best medication. Exercise increases 
serotonin, endorphins etc., which act as antidepressants. 30 
minutes of the daily walk can create a huge difference and 30-
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Table I. Review of MRI and PET neuroimaging techniques (1999-2015) 
 
S.NO TITLE AUTHOR PROCEDURE RESULT LIMITATIONS SCOPE 
1 PET study on 5-
HT2 receptors in 
depression    
 
Jeffrey Meyer 
et al., 1999 
[22]. 
14 patients and 19 
controls were 










Not aware of 










and can be used 








Yatham et al., 
1999 [23]. 
PET scan was 






There was a 




It is not known 
whether changes 
in the receptor 
was due to signs 
of improvement 












et al., 2000 
[24]. 
PET scans were 









of the receptor 
was found to be 
decreased in 
various brain 




The possibility of 
decrease in bp 
values for the 
receptor is not 
mentioned 
More study can 
show whether the 




4 PET study on 
serotonin 
receptors in 
MDD patients  
 
Lakshmi 
Yatham et al., 
2000 [25]. 
PET scanning with 
[18F]Setoperone 
was performed on 
healthy controls 
and MDD patients 
It was noted that 
in both controls 
and patients there 
was a negative 
correlation in the 
binding potential 
of the 5-HT2 










estimate of the 
receptor 
n/a 
5 Challenges in 





Mario Liotti et 
al., 2002 [26]. 
 
The changes in 









decreased in the 
cortex while the 
healthy group 
didn’t show any 
signs  
It is not known 
whether the 
changes show a 
marker of 
vulnerability or  
any changes in 
brain function 





should be studied 
further  
6 Pathophysiology 






volume of the 
n/a Finding out the 
causes of treatment 
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2002[27]. technique 







7 PET study in 
MDD patients 




al., 2004 [28]. 
30 participants 
were divided into 
3 groups. Voxel-
based methods 
were used to 
analyse blow flow 
changes within the 
groups. 





blood flow in the 




The study does 
not access 
differences in sex 
when anger was 
introduced 
MRI could be used  











14 males who had 
faced depression 
previously were 
deployed for the 
study along with 
18 healthy control 
males. PET scan 
was performed 
with 5-HT1A 
receptor   
The binding 
potential of the 
receptor was 




The present data 




We need further 
studies to 
determine how 
there is a reduction 
in this receptor 
9 Neural response 




Cynthia H. Y 
et al., 2004 
[30]. 
fMRI was 
performed twice in 
8 weeks on 2 















n/a Improvement in 
functioning also 
indicates fMRI as 
a useful tool for 
antidepressant 
treatment 






al., 2005 [31]. 
 
PET studies were 
done for about 2 
months in female 
patients. MDD 






was found in right 
regions of the 
brain for MDD 
with BPD and no 
differences were 
noted for MDD 




Data needs to be 
generalized, it can 
be done with 
subjects of both 
genders 













and GABAA is 
suggested  
n/a Focuses only on 
sleep 
disturbances as a 
major aspect for 
MDD 
Can look into other 
factors like fatigue 
and poor appetite 
12 Variations found 
in the brain 




et al., 2008 
[33]. 
The study is 








There was a 
decrease in the 
density of grey 
matter in patients 
when compared 
to controls  
Samples were 
insufficient to 
assess all factors 
for treatment  
Larger samples are 
needed to assess 
this 
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al., 2009 [34]. 
289 twins were 
examined along 
with the control 
group. 4 Minute 
PET scan with 
Nitrogen 13 
ammonia was 
done to calculate 
CFR.  
MDD is not 
related to any 
myocardial 
perfusion defects 





The data could be 
used after error 
correction 
14 Neuroimaging 








brain changes  
In 3 different 
phases 
Found that there 
was increased 
CSF volume in 
MDD patients 
and increased 
white matter in 
BD patients 
compared to 
healthy controls  
Unclear whether 
there are common 
irregularities 
between MDD 
and BD  
These 
abnormalities 
could be risk 
factors for 
amplifying MDD 





Li Wang et 
al., 2012 [36]. 
 
fMRI  was done in 
patients with 









(ALFF) in the 
right region and 
decreased ALFF 
in the left region 
of the brain 
compared to 








regions of the 
brain 
The higher 
sampling rate can 
be used. The 
alterations in the 
brain could 
contribute to 
further studies on 
imbalances related 
to MDD in fMRI 
reports 
16 A meta-analysis 








ALE and Gaussian 
process regression 
(GPR) were used 
to compare data  
Frontal areas 
were noted to be 
treatment 
sensitive 
With more data, 




More research can 
be done on GPR 
and how it models 
heterogeneity 
17 A voxel-based 
meta-analysis of  
PET studies  in 
MDD patients 
 
Liang Su et 
al., 2014 [38]. 
 











decreased in the 
right region in 
patients with 
MDD. It was 
noted that certain 






results as they 











thalamus are to 
play an important 
role 
18 Analysis of the 











studies and throws 
some light on 
GABA studies 
Points out that 









contribute to the 
development of 
various medicines 
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351 patients were  






volume was noted 
in patients, 8% in 
the left and 10% 
in the right 
hemisphere of the 
brain  
n/a Further studies can 
show how 







The patients must engage themselves in social activities and 
spend more time with their families. Apart from this, a 
balanced diet is important for mental and physical health [41]. 
This will help minimize mood swings. A proper sleep pattern 
should also be maintained. One should get at least 8-9hrs of 
sleep. Irregular sleep patterns or inadequate sleep tend to make 
depression worse [1]. 
B. Psychotherapy 
   Psychotherapy involves talk sessions where the patient 
discusses with the therapist about the underlying issue and 
learns the required skills to cope up. There are several 
therapies to treat depression and mood disorders. Commonly 
used therapies are Cognitive behavioural therapy (CBT), 
psychodynamic therapy and interpersonal therapy (IPT). CBT 
helps assess negative thinking patterns connected with 
depression and coping strategies are taught to patients so they 
could overcome it. This therapy is limited to 8-16 sessions 
[42].In psychodynamic therapy, the individual is taught to 
resolve the negative pattern of behaviours and negative 
feelings they experience which are mostly connected to their 
past experiences. IPT is significantly given to improve 
personal relationships with family and friends. It is time-
limited like CBT [42]. A study conducted by Health Quality 
Ontario [43] showed that CBT improved symptoms, clinical 
response and quality of life scores in patients post-treatment. 
Also, patients post-treatment of IPT showed reduced MDD 
scores. It is estimated that the net budget of adding 
psychotherapy to usual care would increase around 7 folds in 
the next 5 years [43]. 
C. Medications 
   Antidepressants take 2-4 weeks to have an effect and 12 
weeks to have a prominent effect. The most common 
medication prescribed for individuals with depression is 
selective serotonin reuptake inhibitors (SSRIs) [1], [41]. They 
consist of paroxetine and fluoxetine [41] that behave on 
serotonin. Serotonin and norepinephrine reuptake inhibitors 
(SNRIs) come second in the commonly available 
antidepressants. They increase the production of serotonin and 
norepinephrine. Venlafaxine and Desvenlafaxine are some 
examples of SNRIs. Second-generation antipsychotics (SGAs) 
treat bipolar disorder, schizophrenia, acute mania and other 
mental illnesses. Mirtazapine is another antidepressant that 
increases brain activity level by targeting specific 
norepinephrine and serotonin receptors.  However, it’s used 
less than newer antidepressants (SSRIs, SNRIs) because it 
leads to weight gain, sleepiness, dry mouth, increase in 
appetite [44] and sedation. Tricyclic antidepressants 
(TCAs) are old medications which are still used today to treat 
depression at its starting stage. TCAs like doxepin and 
amitriptyline help ease chronic pain. They are similar to 
SNRIs but lead to more side effects. They are used when other 
antidepressants don’t work. It has been noted that out of 100 
adult patients who took antidepressants, 40-60 people showed 
improved symptoms after 6-8 weeks [45]. 
 
D. Brain Stimulation Therapies 
   This includes activation or stimulation of the brain directly 
by giving electricity from electrodes embedded in the brain or 
placed on the scalp [46] or by sending magnetic fields. It’s a 
promising treatment and is preferred over psychotherapies and 
medication.   
 
1. Electroconvulsive Therapy (ECT):  
   ECT is most commonly used to treat severe depression 
which is treatment-resistant [46]. It involves sending short 
electrical impulses to the brain. It works quickly, usually 
starting within the first week, and is quickly responded by 
older people. Some common side effects related to ECT are 
muscle aches and headaches. 
 
2. Repetitive Transcranial Magnetic Stimulation (rTMS):  
   This new brain invigoration technique uses a magnet to 
stimulate the brain. It is mostly used to treat anxiety, 
depression and other disorders. It can be targeted to a specific 
region in the brain unlike ECT [46]. Scientists believe that 
when a particular region is focussed, it could reduce side 
effects. 
3. Vagus Nerve Stimulation (VNS):  
   A device is embedded under the skin and this sends 
electrical signals to the left vagus nerve [46]. The nerve then 
carries the messages to the body’s major organs from the brain 
as shown in Fig. 5 [47]. It was initially developed to cure 
epilepsy [48]. Nonetheless, it was later discovered that it has 
favourable effects on mood [48]. Some side effects include 
hoarseness of voice, cough and neck pain. The individual may 
want to stop the function of the side effects become intolerable 
[46]. 
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Fig. 5.Vagus Nerve Stimulation (VNS) 
 
4. Magnetic Seizure Therapy (MST):  
   It’s similar to both ECT and rTMS. The patient is first 
anaesthetized and high-frequency magnetic impulses are then 
given. To prevent muscle movement [46], a muscle relaxant is 
provided. The goal of MST is to perform like ECT while 
lowering its cognitive side effects. 
 
5. Deep Brain Stimulation (DBS):  
   Initially developed as a cure for Parkinson's disease, to 
reduce stiffness and tremor, it is currently used to treat 
obsessive-compulsive disorder (OCD) [46]. DBS uses a pair 
of electrodes which is embedded in the brain. A generator is 
embedded in the chest [46] which controls the electrodes as 
shown in Fig. 6 [49]. Level and frequency are customized as 
per the individual while the stimulation is continuous. 
Scientists believe that it puts the brain malfunctioning area to 
rest so that it starts to work ordinarily. Any type of brain 
surgery comes with the risk. This procedure like others has 




Fig. 6. Deep Brain Stimulation (DBS) 
E. Alternative treatments 
   A good intake of vitamins and supplements with a doctor’s 
prescription may be beneficial to overcome the symptoms of 
depression. Practising relaxation techniques such as doing 
meditation, yoga and deep breathing can help lower stress and 
boost feelings of joy. Acupuncture is another technique where 
minute needles are used on specific points on the body for 
treatment purposes. It rarely has side effects [50]. This method 
is now increasingly used as a treatment for depression and 
further research is ongoing. 
 
II. CONCLUSION 
   The entire review was aimed to provide a clear 
understanding of depression, its symptoms, diagnosis and 
treatment. The focus was to summarize the existing research 
under sub-headings so that it’s easier to locate such vast 
information.  It is to benefit researchers, scientists, professors, 
students and anyone who’s looking to gather an overall 
understanding of depression.  Many techniques to diagnose 
and treat depression have been developed over the years. This 
review focussed on MRI and PET imaging techniques that 
help identify MDDs easily. These techniques have the 
potential to significantly decrease the duration of patient 
suffering. They help in quicker diagnosis and thereby quicker 
treatment, have no adverse effects on the human body, provide 
better image contrast and have less scanning time. MRI/PET 
scans detect abnormal findings that CT scans miss in more 
than 50% of patients scanned. Though there are several 
techniques to diagnose MDD, only about half of the overall 
cases of depression are recognized in primary care settings. 
Although such cases are associated with patients who have 
milder symptoms, this issue should not be neglected. Most of 
the treatment practises fall short of the existing practice 
guidelines. Patient outcomes are good only when the 
guidelines are followed. The most effective treatment option 
for depression is brain stimulation therapies. Of these, ECT is 
the oldest and most widely used procedure. More research 
needs to be done on other therapies to determine their safety 
and effectiveness in treating mental disorders.  
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